Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multi-center, Phase Ⅳ, Single Arm, Open-label Clinical Trial to Evaluate the Efficacy and Safety of Meditoxin® in Subjects With Essential Blepharospasm

NCT01259557 is registered in ClinicalTrials.gov with Medy-Tox as lead sponsor.

NCT NCT01259557
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01259557 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multi-center, Phase Ⅳ, Single Arm, Open-label Clinical Trial to Evaluate the Efficacy and Safety of Meditoxin® in Subjects With Essential Blepharospasm
Lead sponsor
Medy-Tox
Phase
Phase 4
Overall status
Completed
Start date
August 31, 2010
Completion date
August 31, 2011
Enrollment
110 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

essential blepharospasm